Superpower, the company empowering members to take control of their health, today announces the launch of the world’s first health super-app—beginning with the most comprehensive biomarker testing service on the market to deliver proactive, preventative, and personalised healthcare to everyone.
As Pentagon leaders call for thousands of drones to face China, they are grappling with an uncomfortable reality: Silicon Valley is addicted to Chinese drone components.
Canva has moved beyond pretty pictures to pull the threads of AI together into an easy-to-navigate, user-friendly platform for creativity.
Supply chain monitor Fair Supply has launched a tariff calculator to work out what the Trump trade war will cost businesses.
While DOGE dismay has hammered Tesla stock, SpaceX is still flying high with investors as the world’s most valuable private company. But economic realities and the physical limits of beaming internet connectivity from space could puncture the good vibes.
Successful research translation isn’t a matter of pushing more intellectual property into the market. The real catalyst for impact lies in building researchers’ commercial capability from the outset, says CSIRO’s executive manager of Innovation Programs.
With the help of a modern wolf’s genetic code, a Texas-based company says DNA from the extinct dire wolf is now back in living animals.
Cyberhaven, which just raised $100 million at a $1 billion valuation, offers AI tools designed to prevent employees from putting proprietary information into tools like ChatGPT.
For Visa and rival Mastercard, fighting the explosion of fraud attempts is both a big expense–and an opportunity for profit.
New York-based Jones just raised $10 million to expand its nicotine lozenge company in the stodgy, $3 billion smoking cessation market.